Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Rocket Doctor AIAIRDF +7.59%27 5-Year ROIIC % is 0.00 as of Dec. 2025. GuruFocus rates AIRDF with a GF Score™ of 27/100. The stock has 7 warning signs investors should review. Among 533 Healthcare Providers & Services companies, Rocket Doctor AI ranks worse than 187617.07% on this metric.
5-Year Return on Invested Incremental Capital (5-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 5-year.
Rocket Doctor AI does not have enough data to calculate 5-Year ROIIC %.
Rocket Doctor AI (OTCPK:AIRDF) 5-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Rocket Doctor AI 5-Year ROIIC % Related Terms
Rocket Doctor AI 5-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for Rocket Doctor AI's 5-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AIRDF vs VEEV, BTSG, TEM: 5-Year ROIIC % Comparison
For the Health Information Services subindustry, Rocket Doctor AI's 5-Year ROIIC %, along with its competitors' market caps and 5-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Rocket Doctor AI 5-Year ROIIC % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Rocket Doctor AI's 5-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Rocket Doctor AI's 5-Year ROIIC % falls into.
Rocket Doctor AI's 5-Year ROIIC % for the quarter that ended in Dec. 2025 is calculated as:
5-Year ROIIC %
=
5-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
5-Year Incremental Invested Capital**
=
( -9.673 (Dec. 2025) - -2.27 (Dec. 2020) )
/
( 7.276 (Dec. 2025) - 0 (Dec. 2020) )
=
-7.403
/
=
N/A%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 5-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Rocket Doctor AI (AIRDF) has a 5-Year ROIIC % of 0.00 as of Dec. 2025. 5-Year ROIIC % measures the change in earnings as a percentage of change in investment over 5-year. View historical data on Rocket Doctor AI and its competitors. According to the industry distribution chart, Rocket Doctor AI ranks #999999 out of 533 companies in the Healthcare Providers & Services industry.
Is Rocket Doctor AI's 5-Year ROIIC % too high?
Rocket Doctor AI's current 5-Year ROIIC % is 0.00. Based on the distribution chart, Rocket Doctor AI ranks #999999 out of 533 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Rocket Doctor AI has a GF Score™ of 27/100, reflecting its overall financial health beyond just this single metric.
How does Rocket Doctor AI's 5-Year ROIIC % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Rocket Doctor AI ranks #999999 out of 533 companies for 5-Year ROIIC %. This places Rocket Doctor AI in the lower half of its industry. The industry median 5-Year ROIIC % is 3.43. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year ROIIC % for a Healthcare Providers & Services company?
The median 5-Year ROIIC % among Healthcare Providers & Services companies is 3.43, based on 533 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year ROIIC % mean?
A high 5-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 5-Year ROIIC % measures the change in earnings as a percentage of change in investment over 5-year. View historical data on Rocket Doctor AI and its competitors. For the Healthcare Providers & Services industry, the median 5-Year ROIIC % is 3.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Rocket Doctor AI's current 5-Year ROIIC % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rocket Doctor AI stock overvalued right now?
Rocket Doctor AI (AIRDF) has a current 5-Year ROIIC % of 0.00. The current 5-Year ROIIC % is 0.00. Rocket Doctor AI's overall GF Score™ is 27/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year ROIIC % calculated?
5-Year ROIIC % is calculated from a company's financial statements. For Rocket Doctor AI (AIRDF), the current 5-Year ROIIC % is 0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Rocket Doctor AI Inc delivers physician-built, AI-powered solutions designed to make high-quality healthcare accessible throughout the entire patient journey. A cornerstone of the company's proprietary technology is the Global Library of Medicine (GLM), a clinically validated decision support system developed with input from hundreds of physicians world-wide. Alongside the GLM and its AI-powered digital health platform and marketplace. The group empowers over 300 MDs to provide care to more than 700,000 patients. Its proprietary technology software and systems enable doctors to independently launch and manage their own virtual or hybrid in-person practices - improving efficiency, restoring autonomy to MDs, and expanding patient access to care.
27GF Score
Get the complete analysis for AIRDF
5-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AIRDF has been successfully added to your 
